⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 1, 2010Journal of the International AIDS SocietyOpen Access

ARTEMIS: 192‐week efficacy and safety of once‐daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment‐naïve HIV‐1‐infected adults

Chloe Orkin E DeJesus Homayoon Khanlou Albrecht Stoehr Khuanchai Supparatpinyo Tom Van de Casteele Erkki Lathouwers Sabrina Spinosa‐Guzman

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Orkin et al. (2010) studied this question.

synapsesocial.com/papers/6a6afe40f66cb1697bf40558 https://doi.org/10.1186/1758-2652-13-s4-p3

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Predictors of Liver Steatosis Progression Among People Living With HIV in Low‐ and Middle‐Income Countries: A Multicentre Longitudinal StudyJournal of the International AIDS Society · Tue,
2Metabolic Dysfunction‐Associated Steatohepatitis and the Progression of Cognitive Decline in Older Thai People With HIVJournal of the International AIDS Society · Thu,
3Assessing Fidelity to HIV Index Case Testing Protocols in Malawian Clinical Settings: Results From a Cluster Randomized Controlled TrialJournal of the International AIDS Society · Thu,
4Cross‐Cutting Implementation Strategies to Integrate Hypertension Care Into HIV Care in Africa: Results From Six Country Studies in the HLB‐SIMPLe AllianceJournal of the International AIDS Society · Thu,
5Cost‐Effectiveness and Impact of Depression Treatment Implementation on HIV Outcomes in Western Kenya: A Mathematical Modelling StudyJournal of the International AIDS Society · Tue,

More from Journal of the International AIDS Society

Comparing Approaches for Estimating Counterfactual HIV Incidence Among Populations With High Vulnerability to HIV in Lima, Peru: A Multi‐Study Comparative AnalysisTue,
Have We Met Before? Findings on HIV Retesting in Routine Healthcare Settings, Using Eswatini HIV‐1 Recent Infection Surveillance DataTue,
Understanding Adolescent Anti‐Retroviral Therapy Use in the BREATHER‐Plus Trial: Qualitative Findings From South Africa and UgandaTue,
Prevalence, Patterns and Implications of Chemsex Substance Use Among Gay and Bisexual Men Who Have Sex With Men: A Cohort‐Collaboration Between the Swiss HIV Cohort Study and the SwissPrEPared StudyTue,
Adding a Prevention Intervention to an Established App: The Blued+ HIV Prevention Pilot Study in Beijing and Chengdu, ChinaTue,